PHE377: A novel clinical-stage TRPV1 antagonist devoid of “class” side effects for the treatment of chronic pain syndromes Summary of the Opportunity PharmEste wishes to identify a partner for development and commerc

First Page		Document Content
Date: 2012-11-09 04:33:07 Biology Perception TRPV1 Capsaicin TRPV Neuropathic pain Discovery and development of TRPV1 antagonists Hyperalgesia Piquance Pain Ion channels Mind		PHE377: A novel clinical-stage TRPV1 antagonist devoid of “class” side effects for the treatment of chronic pain syndromes Summary of the Opportunity PharmEste wishes to identify a partner for development and commerc Add to Reading List Source URL: www.pharmeste.com Download Document from Source Website File Size: 63,27 KB Share Document on Facebook

	Raccoons, Skunks and Opossums – Oh My! How to Stop Wildlife from Moving In Prevent Unwanted Wildlife Situations Deter Wildlife from Your Home DocID: 1r2Ku - View Document
	C. QUEIROZ, M. AZEVEDO, I. LEITE, E. FIALHO Universidade Federal do Rio de Janeiro, Instituto de Nutrição Josué de Castro Departamento de Nutrição Básica e Experimental E-mail: ABSTRACT DocID: 1qDzZ - View Document
	B’SYS GmbH CHO TRPV1 Cell Line Specification Sheet © B’SYS GmbH DocID: 1q9uB - View Document
	doi:j.phymed DocID: 1pD2S - View Document
	Riot Control Agents Chapter 12 RIOT CONTROL AGENTS FREDERICK R. SIDELL, M.D. * DocID: 1oupL - View Document